0R55BioSenic S.A.

Data unavailable

—Mkt Cap: —P/E: —126d ago

BioSenic S.A., a biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France. The company offers arsenic trioxide (ATO) and oral arsenic trioxide (O…

Key Statistics

Company

Market Cap—

Enterprise Value26.45M $

Revenue (TTM)-2.59M $

Gross Profit-2.59M $

Net Income (TTM)-4.34M $

Revenue/Share-0.0065 USD

Last Price—

Fiscal Year EndDec 2024

MR QuarterJun 2025

Employees7

CountryGB

Sector—

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-5.06

EV/Revenue-10.19

P/S—

P/B-0.06

EPS (TTM)-0.77

EPS (Forward)—

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin0.00%

Oper. Margin-70700.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE—

ROA-46.20%

Growth

Revenue Growth-100.00%

Earnings Growth—

Cash Flow & Leverage

Operating CF-1.98M $

CapEx (TTM)—

FCF Margin145.17%

FCF Yield—

Net Debt25.03M $

Net Debt/EBITDA-4.79

Balance Sheet

Debt/Equity—

Current Ratio0.53

Quick Ratio0.50

Book Value/Sh-0.0360 EUR

Cash/Share0.0010 EUR

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 EUR

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.7.83M

Float603.17M

Insiders14.14%

Institutions0.00%

Technical

SMA 500.0410 EUR

SMA 2000.0628 EUR

Beta-1.60

S&P 52W Chg16.25%

Avg Vol (30d)—

Avg Vol (10d)3.90K

Technical Indicators

RSI (14)43.0

MACD-0.0001

MACD Signal-0.0001

MACD Hist.-0.0000

BB Upper0.0023 EUR

BB Middle0.0021 EUR

BB Lower0.0019 EUR

BB Width19.54%

ATR (14)0.0002 EUR

Vol Ratio (20d)0.04x